In Hodgkin's disease (HD), the Hodgkin and R.eed-Sternberg (HR.S) cells represent only a minute population in the diseased tissue. The investigation of lineage derivation and clonal origin of these cells has yielded conflicting results. We have analyzed HRS cells micromanipulated from infiltrated tissue sections of 10 primary HD patients for rearranged V genes, extending a previous study. Clonally related rearrangements were found in nine cases, indicating that HRS cells represent a dominant clone of B lineage-derived cells in at least a large fraction of cases of liD. Rearranged V. genes from HP.S cells carried a high load of somatic mutation, indicating that HRS cells are derived from germinal center (GC) cells or their progeny. Stop codons in some in-frame V gene rearrangements suggest that the HR.S ceil precursors reside inside GCs, have acquired crippling mutations that prevent antigenic selection, but escape apoptosis through some transforming event.
Summary
In Hodgkin's disease (HD), the Hodgkin and R.eed-Sternberg (HR.S) cells represent only a minute population in the diseased tissue. The investigation of lineage derivation and clonal origin of these cells has yielded conflicting results. We have analyzed HRS cells micromanipulated from infiltrated tissue sections of 10 primary HD patients for rearranged V genes, extending a previous study. Clonally related rearrangements were found in nine cases, indicating that HRS cells represent a dominant clone of B lineage-derived cells in at least a large fraction of cases of liD. Rearranged V. genes from HP.S cells carried a high load of somatic mutation, indicating that HRS cells are derived from germinal center (GC) cells or their progeny. Stop codons in some in-frame V gene rearrangements suggest that the HR.S ceil precursors reside inside GCs, have acquired crippling mutations that prevent antigenic selection, but escape apoptosis through some transforming event.
T he Hodgkin and Reed-Sternberg (HRS) 1 ceils, which are considered to represent the malignant tumor cell population in Hodgkin's disease (HD), still pose riddles as to their origin and clonality. In contrast to the abundance of tumor cells in other neoplasias, the HRS cells in HD (usually ~1% of cells) reside within a complex admixture of lymphocytes, plasma cells, histiocytes, eosinophils, and other cells. The composition of the cellular background and morphological criteria have led to the subdivision of HD into the three "classical HD" subtypes, namely, nodular sclerosing (NS), mixed cellularity (MC), and lymphocyte depleted (LD), besides the fourth subtype, lymphocyte predominant (LP) (1, 2) . HRS cells of the NS, MC, and LD categories of HD express the activation markers CD30 and CD15 as detected by immunohistochemistry (3) . In the LP subtype, HRS cell variants often lack these antigens but express several B cell-associated molecules, and therefore are commonly accepted to be of B lineage origin (4) .
Despite considerable effort, lineage derivation and clonality of the HRS cells in classical HD are controversial (3, 5) .
1Abbreviations used in this paper: FR, framework region; GC, germinal center; HD, Hodgkin's disease; HRS, Hodgkin and Reed-Sternberg; LD, lymphocyte depleted; LMP, latent membrane protein; LP, lymphocyte predominant; MC, mixed cellularity; NS, nodular sclerosing.
H. Kanzler and R. Kfippers contributed equally to this work. This is mainly due to the sparseness of the HRS cells and difficulties encountered in attempts to isolate these cells (6, 7) . Immunohistochemical studies yielded conflicting results, revealing B and/or T cell markers on HRS cells and occasionally also monocyte markers (3) . In a recent study of HRS cells at the level of single cells, expression of genes characteristic of several hematopoietic lineages was found (8) . Furthermore, Southern blot hybridization and PCR approaches for the detection of Ig or TCR gene rearrangements using whole tissue DNA from HD infiltrates (as successfully perfomed on other lymphomas) detected such rearrangements only in a small number of cases (5) . These population-based approaches now are considered inappropriate because of low sensitivity and the inherent inability to specifically assign rearrangements detected to the sparse HRS cells (9) . However, the demonstration of clonal numerical chromosome aberrations in HRS cells and EBV genome studies suggest a monoclonal origin of HRS cells (10) (11) (12) .
Recently, we overcame the problems associated with the small number of HRS cells by isolating individual HRS cells from frozen sections by micromanipulation and analyzing them by amplification of gene rearrangements (13) . Using this approach, the HP,.S cells in four cases of HD (2 ofMC, 1 of NS and 1 of LP subtype) were found to represent a single clone and to originate from the B lineage, because Ig V gene rearrangements are restricted to B lineage cells and highly specific for a B cell clone (13, 14) . Single-cell approaches have also been applied by other groups to the analysis of classical HD, but with differing results (15, 16 ; see Discussion). P,.oth et al. (15) Immunostaining and Micromanipulation. Immunohistochemical staining procedures using antibodies against CD30, CD20, Ki67, LMP1 (Dako, Hamburg, Germany), CD15 (Becton Dickinson & Co., Mountain View, CA), and CD3 (Ortho Diagnostic Systems, Inc., R.aritan, NJ) were as described in our previous publications (18, 19) . The stained sections were overlaid with Tris-buffered saline (TBS), and single cells were isolated under the microscope (Olympus, Hamburg, Germany; 600• with the help ofmicropipettes fixed to hydraulic micromanipulators (see Fig. 1 ) (18, 19) . Isolated cells were transfered into 20 p,1 PCR buffer (20 mM Tris-HC1, pH 8.4, 50 mM KCI) containing 1 ng/l~l 5S rR.NA (Boehringer Mannheim GmbH, Mannheim, Germany) and stored at -80~ Single CD30 + HR.S cells and CD3 + T cells were obtained from adjacent sections of the same specimen. In a few experiments (see Table 2 , experiments 2a and 8), single mantle zone B cells were micromanipulated from a Ki67 stained tonsillar section of another individual. The isolated cells were coded and analyzed in a blinded fashion. In the repeat experiments, separate sections were analyzed following the protocol outlined above.
Sorting of lgD + and IgA + Peripheral Blood B Cells. PBMC were isolated by Ficoll gradient centrifugation (PAQUE R.; Pham~a-cia/LKB, Uppsala, Sweden). B cells were enriched by magnetic cell sorting using the MACS system and anti-CD19 beads (Miltenyi Biotec, Bergisch-Gladbach, Germany) (20) Single-Cell PCR. Rearranged Ig genes were amplified from single cells using the seminested PCR. approach and V-gene family--specific primers together with JH and JK primers as described previously (18, 19) . Briefly, single cells in 20 jxl PCR. buffer were incubated with 0.25 mg/ml proteinase K for 1 h, subsequently inactivating the enzyme at 95~ for 10 min. In the same tube, the first amplification round was carried out with 20 mM Tris-HC1, pH 8.4, 50 mM KCI, 2.5 mM MgCI2, 100 IxM each dATP, dGTP, dCTP, and dTTP, 6.9 nM each Vt~, VK, 3'Jw, and 3'JK primer (19) , and 1.25 U ofTaq DNA polymerase (GICBO BRL, Gaithersburg, MD) in a total volume of 50 Ixl. The PCR consisted of one cycle of 95~ for 2 min, 65~ for 5 min, and 72~ for 1 rain, followed by 34 cycles of 95~ for 1 min, 59~ for 30 s, and 72~ for 1 min, followed by 72~ for 5 min. Enzyme was added during the 5-min incubation at 65~ A 1-1xl aliqout of the first round was reamplified in a second round in separate reactions for each of the six VH and six V K family-specific primers. The 50-1xl reaction mix of the second PCP~ contained 20 mM Tris-HC1, pH 8.4, 50 mM KC1, 2.5 mM MgCI: (1,5 mM for V, primers), 100 I~M of each dATP, dGTP, dCTP, and dTTP, 0.125 IxM of one of the V H or V~ primers together with 0.125 jxM of the respective 5'Jt~ or 5'J, primer mixes, and 1.25 U Taq polymerase (GIBCO BP,.L). The cycle progam was the same as for the first round except that the annealing temperature in the first cycle was 68~ and the annealing temperature in the following 44 cycles was 61~ (65~ for VH3 and VH4). Amplification was performed in a thermal cycler (model 480 Perkin Elmer, Foster City, CA, or Trio-Thermoblock; Biometra, G6ttingen, Germany). An 8-1xl aliquot of the reaction mix was analyzed on a 2% agarose gel. The primers used have been published elsewhere (19) . The following modifications were introduced: a new JH3-specific primer (5'-GAC GGT GAC CAT T G T CCC T T G GCC-3') was used in the second round of amplification and primer 5'Jiq 1,3,4,5 was modified to 5'-GAC GGT GAC CAG GGT KCC CTG GCC-3'. In some experiments, V . gene family-specific framework region (FR) I primers (19) in the first round of P C R were exchanged for a set ofVH FRII primers (Kanzler, H., R. Kippers, M.-L. Hansmann, and K. Rajewsky, unpublished results). The Vxl rearrangement in patient 2 was amplified with a Vxl family--specific primer and a set of nested J• primers (Kippers, R., M.-L. Hansmann, and K. Rajewsky, unpublished observation).
Sequence Analysis. P C R products were gel purified from 2.5% agarose gels using a gel extraction kit (Qiaex II; Qiagen, Hilden, Germany) and directly sequenced. Cycle sequencing was performed using the Ready Reaction DyeDeoxyTerminator cycle sequencing kit (Perkin Elmer, Foster City, CA) and automatic sequencing (Applied Biosystems/Perkin Elmer) or the ds cycle sequencing system (GIBCO BRL) following the instructions of the manufacturer. Sequencing primers were the same as in the second round of amplification. DNASIS software (Pharmacia/ LKB) and the GenBank data library (release 92) were used to analyze the V gene sequences. For patient 10, the VH3 gene rearrangement amplified twice in experiment 10a was different than the VH3 rearrangement in experiments 10b and 10c, whereas identical VH3 gene rearrangements were obtained in experiments 10b and 10c. *Among 8 PCR products from HRS cells not sequenced were one VK3 gene rearrangement (experiment la), one VK2 gene rearrangement (experi-sue sections of LN biopsies and analyzed by single cell P C R (Fig. 1 ). The panel of cases analyzed consisted of 10 primary H D patients, 6 o f the NS and 4 o f the M C subtype (Table 1) . H R S cells did not detectably express the CD20 and CD3 markers. In 50% of the patients, the presence of EBV could be detected by latent membrane protein (LMP) 1 immunostaining (Table 1 ). In 5 of the 10 cases, a repeat experiment was carried out. Cases 5 and 10 were examined three times ( Table 2) . As negative control, single T cells micromanipulated on the same day as the H R S cells from a CD3-stained adjacent section of the same LN were analyzed together with the H R S cells in a blinded fashion. As positive control, single IgD + peripheral blood B cells were sorted by flow cytometry and analyzed in parallel with the H R S and T cells ( Table 2, 
Results

PCR Analysis of Isolated FIRS Cells. Single C D 3 0 + H R S cells were micromanipulated from HD-infiltrated frozen tis-
HRS Cells Harbor Clonal (g Gene Rearrangments.
From each H D patient, between 17 and 52 individual H R S cells were analyzed for Ig gene rearrangements (Table 2) . From a total o f 304 H R S cells, 118 yielded amplification products. In the nine cases in which rearrangements were identified, the efficiency of amplification from the H1KS cells varied from 20 to 89% positive cells in different experiments. Direct sequencing of the P C R products confirmed that the H1KS cells indeed carried rearranged VH and/or VL gene rearrangements (Table 2) . Furthermore, the vast majority o f Ig V gene rearrangements gained from HIKS cells of the same case were clonally related, with one possible exception (see below).
N o Ig gene rearrangements were amplified from the HIKS cells from patient 9, even when we exchanged the V , gene family-specific FRI primers in the first round of P C R by a set of FPdI primers ( Table 2 ). The FRII primer set was used to detect potential VH gene rearrangements that could not be amplified with VH FRI primers (e.g., because of somatic mutations; see Discussion). The V , FR.II primer set or a group ofV~ gene-specific primers were also used to investigate H R S ceils from other patients. Except for the amplification o f a clonal Vxl gene rearrangement in H R S cells from patient 2, this did not lead to the detection of Ig gene rearrangements beyond those already identified (Table 2 and data not shown).
In the case of patients 1-3, 5-7, and 10, repeat experiments were performed. Identical Ig V gene rearrangements were detected, with one exception (patient 10, see below). For patient 5 (the case with only 20% amplification efficiency), a third experiment was carried out yielding the same results as in experiments 5a and 5b. The results in repeat experiments 10b and 10c differed from those in experiment 10a. Whereas in experiment 10a a number of clonally unrelated Ig V gene rearrangements were obtained besides two H R S cells harboring a related VH3 gene rearrangement, H R S cells in experiments 10b and 10c showed a VH3 gene rearrangement differing from the one in experiment 10a but identical between the two repeat experiments.
Sporadically, HR.S ceils also gave rise to Ig V gene rearrangments that were not related to the clonal rearrangement(s) carried by the majori W of H R S cells from the respective case (Table 2) . These "unique" rearrangements were detected in 11 out of 304 (3.6%) o f H R S cells analyzed (the unique Ig gene rearrangements obtained in experiment 10a are discussed below). T cells included as controls for cellular or other contamination gave rise to Ig gene rearrangements with about the same frequency (6 out of 132 [4.5%] o f T cells analyzed; Table 2 ), suggesting that the unique Ig gene rearrangements amplified from H R S cells were also due to cellular or other contamination. Indeed, the unique Ig gene rearrangements from H R S and T cells were either unmutated or harbored between 0.5 and 6.3% mutation (on the average 2.5% for mutated rearranged V genes). Because naive B cells with unmutated V genes as well as memory B cells (harboring on the average 4% mutation) are present in human LNs (18, 21, 22) , the mutation ment 3a), one VH2 gene rearrangement (experiment 4), one VH4 and one VK3 rearrangement (experiment 5a), one V~3 rearrangement (experiment 7b), and two VH4 gene rearrangements (experiment 10a). :~HI<S cells from patient 2 (27 HtkS cells), patient 3 (11 HP,.S cells), patient 5 (7 HIkS cells), patient 6 (10 HP, S cells), and patient 7 (11 HRS cells) were analyzed for Ig V a gene rearrangements. Because rearranged Vx genes from the HIR.S cells of patient 2 only were amplified, data from this case only are included. ~Vw gene primers annealing to the FP, II were used instead of the V H FP,.I primer set (in experiment 9, 8 HRS cells were analyzed using the VH FP, I primer set and 9 cells using the V H FRII primer set). IJUnique rearrangements (two sequenced, two not sequenced) originate from one cell. I  CDR II  26  28  30  31  33  34  35  35b 40  50  51  53  56  57  59  60  62  67  69  76  78  81  82a B2b 83  89  90  V4-31  GGT TCC AGC AGT GGT TAC TAC AGC CAC TAC ATC TAC AGC ACC TAC AAC TCC GTT ATA AAC TTC AAG AGC TCT ACT GTG CDR II  25  30  31  33  34  38  40  49  ~-53  55  62  66  68  69  70  74  75  76  ~7  79  80  82a 85  89  94  V71-5 TCT ACT AGC C~2T GTG CGA GCT GGA ATC GGC C43T AAG AGA ACC ATT ACC TCC ACA AGC ACA TAC A~G AGC GAG GTG GCA Pat.#2 .. I  CDR II  25  28  30  31  33  45  46  50  51  52a 55  56  57  58  59  60  62  73  75  76  79  81  84  89  94  V3-30 TCT ACC AGT AGC GGC CTG GAG GTT ATA TAT AGT AAT AAA TAC TAT GCA TCC AAT AAG AAC TAT CAA GCT GTG AGA Pat, #4 --c -At G-g -A--A---a C--A .... t --c -A---A -C---t -C--T---t --c G . ... G -T---C -T---a -Cd.} CDR I  CDR II  25  28  29  30  35  41  44  49  52  52b 52c 53  54  55  57  58  60  61  63  64  74  75  77  78  79  81  82  82a 82b 83  84  85  88  89  93  94  9-1 TCT ACT TTC AGT AGC CCA GGG GGC AA.% AAA ACT GAT C43T GGG ACA GAC GCT GCA GTG AAA TCA AAA ACG CTG TAT CAA ATG AAC AGC AAA ACC GAG GCC GTG ACC ACA pattern found for the unique lg gene rearrangements is compatible with a derivation of those products from polyclonal, surrounding t3 cells. They thus most likely represent cellular contamination during the micromanipulation procedure. This is strongly supported by the fact that the sequence characteristics of the clonal gene rearrangements carried by the HRS cells distinguish them from those of normal B cells (see Discussion).
e.)
CDR I CDR II 25 30 31 32 41 44 48 53 54 56 57 61 62 63 65 72 75 76 81 82 82a 82b 83 89 91 94 VI-8
Rearranged V Genes in HRS Cells Have Been Affected and Sometimes Silenced by Somatic Mutation.
The sequences of the clonal VH gene rearrangements amplified from HRS cells are shown in Fig. 2 and the results summarized in Table 3. The VH gene sequences carried between 5 and 45 nucleotide differences (2.2-19.6%) compared with the most homologous germline genes. The vast majority of these nucleotide substitutions can be reliably assigned to somatic mutations because most human VH genes are now known (24, 28) . In this study, this is evidenced by the sequence analysis of V, genes amplified from naive IgD + B cells (which are known to carry unmutated V genes) (21, 22, 29) for control. Among 55 V, genes amplified from B cells from two donors, 48 were 100% homologous to published germline genes. Seven sequences harbored between one and eight nucleotide differences (on the average three to four differences) to the most homologous germline genes (R. Kiippers, H. Kanzler, M.-L. Hansmann, and K. Rajewsky, unpublished observation). That the HRS cellderived V gene rearrangements have indeed been subject to somatic hypermutation is further confirmed by the pattern of nucleotide substitutions. A striking similarity to nucleotide substitution preferences found for somatically nmtated mouse Ig passenger transgenes was observed (Table 4) (for review see reference 30).
Some of the clonal V<J~ sequences from HRS cells also carried mutations (unambigious in these cases because all human VK genes have been sequenced) (26) while others did not. We tentatively attribute the absence of somatic mutation in the latter to the particular genomic structure of the human V K gene locus that allows the presence of unmutated rearranged V~ genes in a B cell with a somatically mutated V H gene rearrangement (see Discussion) (31) .
In the HRS cells from patient 1, we found evidence for Table 3 . (24) (25) (26) (27) . In patient 1, evidence for intraclonal diversity of the VH4 gene rearrangement was found. *Out-of-frame rearrangement (-); in-frame rearrangement (+). :~All V light chain gene rearrangements are V, gene rearrangements except for a Val gene rearrangement in patient 2 (LV122) (27) . ~V71-5 is a pseudogene with a defective splice site. IIIn-frame rearrangements that are nonfunctional because a stop codon was introduced by somatic mutation. 82 H gene rearrangement with a 27-bp deletion in FRill and stop codons in FRII and CDRII. intraclonal diversification of the V H gene rearrangement with identical substitutions at four positions of the V gene in 5 of the 12 H R S cells (Fig. 2) . In all other patients the clonally related V gene rearrangements did not show sequence variation. In patient 4, 1 of 14 otherwise identical H R S cells carried a single base substitution. The absence of deletions or insertions in the clonal sequences except for a 27-bp deletion ofcodons 75-82a of the VH gene rearrangement in H R S cells from patient 10 contrasts previous studies in which we detected aberrant V gene rearrangements in four of seven VH region genes (13, 14) . Three of the four V H gene rearrangements with deletions and insertions were derived from two relapse patients who had undergone therapy before. This may indicate that deletions and insertions in rearranged V genes occur in the course of therapy (32, 33) . A m o n g the eight clonally related VH gene rearrangements in the collection, the rearrangements from patients 4, 5, and 7 could potentially be translated into protein (Table  3 ). The VH1 gene in patient 2 was also rearranged in-frame, but because the most homologous V71-5 germline gene is a pseudogene (because of a mutated splice site outside the region amplified in our study), functionality of that rearrangement is unclear. Overall, the frequency of potentially functional Ig gene rearrangements was low in H R S cells. In patient 1, only an out-of-frame V H gene rearrangement was detected. The 1-9III VH3 gene rearrangement in patient 8 and the V3-9 VH3 gene rearrangement in patient 10 were
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rearranged in-flame but rendered nonfunctional because of stop codons introduced by somatic mutation (Fig. 2 and Table 3 ). A stop codon most likely derived from somatic mutation was also found in the in-frame LV122 Va gene rearrangement in patient 2. (15) to detect V H gene rerarrangements in HR.S cells from any of 13 HI) cases (including 12 classical H D cases) could result from a technical difference between their work and ours, namely, the more stringent hybridization conditions that were used in their P C R analysis. As most V H gene rearrangements in H R S cells carry a high load of somatic mutations (Table 3) , nmtations at the sites of primer binding might have prevented successful amplification of such rearrangements in the work of R o t h et al. (15) . In another recent article, Hummel et al. (16) reported on H R S cells harboring polyclonal VH gene rearrangements in 6 of 12 cases of HD. Both polyclonal and clonal populations of H R S cells were present in three further cases, and in only three cases, HP, S cells represented a single tumor clone. However, these initial findings were later partly corrected (35) . In a reanalysis of the cases previously classified as polyclonal, HR.S cells in 2 cases now turned out to carry clonally related V gene rearrangements (we analyzed one of these cases in parallel with an identical result) (36) . In two cases, polyclonality of HR.S cells was again found; lack of material prevented reanalysis of the two remaining cases (35) . Given this confused situation, the work of Hummel et al. (16, 35) neither supports nor argues against the present data. Furthermore, the relevance of the study by Hummel et al. for a characterization of clonality and lineage derivation of H R S cells in typical cases of classical H D is unclear, because it is restricted to a small subset of cases of classical H D (~1 0 -15%) (3), namely, those in which the H R S cells express the B cell antigen CD20 (37) (38) (39) . In our analysis, cases of classical H D lacking expression of CD20 were analyzed ( Table 1) .
The HR.S cells from one patient in our collection (patient 10) carried a number ofclonally unrelated V gene rearrangements in one of three experiments ( Table 2 , experiment 10a). Reevaluating the histological section used in experiment 10a, we recognized that the CD30 + cells were smaller than typical H R S cells. It is known that EBVinfected B cells in infectious mononucleosis can express CD30 and have an H R S cell-like morphology (40) . Thus, a possible explanation for the clonally unrelated V gene rearrangements amplified from CD30 + cells in experiment 10a is that we mistakenly isolated CD30 + EBV-infected bystander B cells (two of which happened to be clonally related). Unfortunately, presence of EBV could not be determined in the region of the LN from which cells micronlanipulated in experiment 10a were derived. However, as revealed by the repeat experiments 10b and 10c, this patient also harbored a dominant clone of H R S cells (Table 2) .
In 1 of the 10 patients (patient 9), we could not detect any VH or VK gene rearrangement in H R S cells using either the standard FRI VH and VK primer sets or a set o f F R I I V H and V~ primers ( Table 2 , experiment 9). This failure could be due to somatic mutations at the primer binding sites. Alternatively, the H R S cells of this patient were not derived from B lineage cells. The occasional expression of T cell antigens on H R S cells is compatible with a T cell origin of H R S cells in a minor fraction of l i D (3) .
H R S Cells Seem to Ort[~,inate from Germinal Center (GC) B Cells Tkat at Least in Part Acquired Cripplit(~, Somatic Mutations Preventing Antigenic Selection.
All clonally related VH genes anaplified from HtLS cells in this study showed multiple nucleotide substitutions when compared with the most homologous germline genes ( Fig. 2 and Table 3 ) and, as discussed in the Results section, most of these nmst have been introduced by the process of somatic hypemmtation. The finding of unmutated, out-of-frame V~ gene rearrangements in patients 3 and 6 does not exclude that these cases also harbor somatically mutated rearranged V genes that we failed to amplify. Deletion of the K enhancers in k-expressing B cells likely prevents somatic hypernmtation of retained VcJ K joints, so that unmutated V, gene rearrangements can be amplified from B cells carrying nmtated V , and V x genes (31) . Indeed, nmtated, rearranged V H genes were identified in H R S cells from patients 2 and 7 that also harbored unmutated, out-of-frame V~ gene rearrangements (Table 3) .
The frequency of somatic mutations in V H genes amplified from HR.S cells varied from 2.2 to 19.6% (Table 3) . On average, H R S cells showed 10.7% somatic mutation in rearranged V H genes. This contrasts to an average of 4 and 2% in human class-switched IgG + and lgM + memory B cells (21, 22, 29) . The significantly higher average nmtation frequency of the clonal Ig gene rearrangements amplified from H1LS cells as compared to the nmtation frequency of normal human B cells is a further strong argument against a potential contamination of the isolated H R S cells by surrounding B cells.
The finding of V gene rearrangements and somatic mutations in H R S cells allows one not only to assign these cells to the B lineage but also to determine the developmental stage of the B cell that was the precursor of the tumor clone. Because the process of somatic hypemmtation appears to be restricted to B cells undergoing proliferation and antigen selection in the microenvironment of GCs (18) , the finding of somatic mutations in the VH genes amplified from HRS cells suggests that HRS cells originate from GC B cells or their progeny. In retrospect, this also holds true for two previously published cases of HD (NS and MC) (13) . At that time, the limited knowledge of the human VH gene locus did not allow us to identify with confidence somatic mutations in the VH gene rearrangements carried by the corresponding HRS cells. Furthermore, the presence of two nonfunctional V. gene rearrangements in the case of MC HD led us suspect that in this instance the HRS cells originated from an early B cell progenitor that had failed to carry out a functional VH gene rearrangement on either of its two IgH alleles (13) . However, when we reanalyzed those sequences with the present knowledge of the human IgH locus, it became clear that the rearranged VH genes of both cases harbor somatic mutations (with a frequency of 2 and 3% in the two VH genes from the case ofMC HD and 16% in the case ofNS HD). Thus, also in these cases the HRS cells appear to be derived from GC B cells or their progeny.
Strikingly, we observe in several instances in-frame V gene rearrangements that were apparently rendered nonfunctional by somatic mutation, In this study, stop codons generated by somatic mutation were seen in three of nine cases from which Ig gene rearrangements could be amplified (VH genes in patients 8 and 10 and the Vx gene from patient 2). The situation in patient 8 is particularly informative, because two VH gene rearrangements were amplified from the HRS cells, excluding the presence of a potentially functional VH gene on the second allele. Similary, the HRS cells from the MC HD patient in our previous study (13) carried a nonproductively rearranged VHD~H rearrangement in addition to an in-frame one, the latter rendered nonfunctional by a stop codon in CDRIII. In light of the other cases, it seems straightforward to assign the introduction of this stop codon to somatic hypermutation as well.
Under physiological conditions, GC B cells are strongly selected for the expression of high-affinity antibodies. Only cells fulfilling this criterion are allowed to persist in the GC microenvironment and to finally leave it in order to join the pool of memory B cells (41) . Thus, B cells bearing V gene rearrangements rendered nonfunctional by somatic hypermutation can only occur within GC and cannot represent postgerminal center cells. This suggests that at least those HRS cells that carry such a rearrangement originate from precursor cells that underwent a transforming event either before their entry into or within a GC, such that they escaped apoptotic death in the absence of antigenic selection. This may also hold true for those cases of HD in which we failed to detect mutations in V gene rearrangements that would preclude Ig expression. With one exception (14), we did not detect potentially functional, in-frame rearrangements for both H and L chain V regions in any HRS cell. In addition, in cases of potentially functional rearrangements, we might have missed deleterious mutations outside the region that was amplified. And perhaps most importantly, even if still able to express lg, a precursor cell might lose its ability to bind antigen through somatic mutation of its antibody-binding site. The high load of somatic mutations in a large fraction of HRS cells goes well along with these possibilities. Independence of selection for expression of functional surface Ig might also result in downregulation of Ig expression in cases in which V gene rearrangements were not rendered nonfunctional because of crippling mutations as well.
HRS Cell Progenitor Generation: A Scenario. In light of the molecular data presented above, a hypothetical unifying scenario of the pathogenesis of HD can be envisioned. In this scenario, the key feature of the progenitor cell from which the HRS cells derive is that it survives in the GC, although, because of somatic mutation, it has lost its ability to be selected by an appropriate antigen--a prerequisite for normal B cells to survive in the GC microenvironment. Thus, in contrast to most other B cell lymphomas (2), the HRS cells in HD are independent of surface Ig expression and indeed have usually been found not to express antibody (3, 5) . In this respect, classical HD is the true counterpart of follicular lymphoma, which also originates from a GC cell, but in this case a cell that still depends on signals through its antigen receptor (42) . Consistent with its GC origin, follicular lymphoma is characterized by ongoing somatic hypermutation (42) , whereas the process of hypermutation is largely abrogated in HRS cells (Fig. 2 and Table 3 ). This latter finding may indicate that somatic hypermutation requires triggering of the cell through its Ig receptor. Alternatively, abrogation of somatic hypermutation in HRS cells might be due to the disruption of the GC microenvironment (considered to be necessary for the process of somatic hypermutation) during tumor expansion.
Which transforming event has hit the HRS cell progenitor such that it survives in the absence of antigenic selection? It seems reasonable to think that this event should result in the premature upregulation of the gene that is known to protect GC cells from apoptosis, namely, bcl-2 (43); indeed, in a large fraction of HD, HRS cells express bcl-2 protein (44, 45) . It is an intriguing possibility that protection of the HRS cell progenitor from apoptosis through bcl-2 upregulation might be accomplished by EBV infection: EBV has been detected in more than half of the cases of classical HD, where it is found in virtually all HRS cells (3, 46) . Significantly, EBV-harboring HRS cells commonly express the LMP-1 gene (46) (all five EBV-positive cases in Table 1 ), which is known to upregulate expression ofbcl-2 (47) .
In this picture of the early events in the pathogenesis of HD, many questions remain unanswered. Thus, it is not clear whether HRS cells develop from a progenitor that had been infected by EBV before entry into the GC (in EBV-positive individuals the frequency of infected B cells is in the order of 10 -5) (48) or EBV infection takes place in the GC itself. It also remains to be resolved whether in cases of EBV-negative HRS cells other mechanisms of transformation are involved or EBV has still played a role, through a mechanism of"hit-and-run" (49) . Furthermore, rescue of "failed" GC cells from apoptosis can only be a first step in the series of events that finally leads to the development of HD. GC cells rescued from apoptosis might continue to proliferate in the GC microenvironment and further accumulate somatic mutations, thus being at an increased risk to acquire further genetic changes leading to malignancy. Such events may be promoted in GC ceils by the occasional failure to properly target somatic hypermutation to rearranged antibody V region genes.
Taken together, this analysis demonstrates that in at least the major fraction of cases of classical HD, HRS cells represent a clonal population of B lineage cells. The presence of a high load of somatic mutations, together with the detection of mutations rendering Ig genes nonfunctional, suggests that these ceils originate from a precursor located within the GC, which because of crippling somatic mutations had lost its ability to be selected by antigen and was prevented from apoptosis by a transforming event.
